Cite
HARVARD Citation
Disanto, G. et al. (2021). De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis. Multiple sclerosis. pp. 1230-1239. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Disanto, G. et al. (2021). De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis. Multiple sclerosis. pp. 1230-1239. [Online].